HU 331
HU 331 (HU 331) is a highly specific Topoisomerase II inhibitor with anticancer activity. HU 331 has shown promising inhibitory effects on human cancer cell lines in vitro and human tumor xenografts in nude mice in vivo[1].
Product Specifications
CAS Number
[137252-25-6]
Product Name Alternative
VCE 004
UNSPSC
12352211
Hazard Statement
H302-H361
Target
Topoisomerase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hu-331.html
Smiles
CC([C@H]1[C@H](C2=C(C(C(CCCCC)=CC2=O)=O)O)C=C(CC1)C)=C
Molecular Formula
C21H28O3
Molecular Weight
328.45
Precautions
P264-P270-P280-P330-P405-P501
References & Citations
[1]Kogan N M, et al. HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor[J]. Molecular Cancer Therapeutics, 2007, 6 (1) : 173-183.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topo II
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9014858 Inquire
Rabbit anti-Escherichia coli MCJA Polyclonal Antibody
Sign In for Pricing
View Details 
127089-ML405 100 µL
GAD1 (Glutamate Decarboxylase 1, 67kD Glutamic Acid Decarboxylase, GAD-67, Glutamate Decarboxylase 67kD Isoform, GAD, GAD67) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
46936111 3x 1.0 µg
TMEM17 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details